Current position:Home >Product >
1-Naphthalenecarboxamide, N-[(3aR,6S,6aS)-octahydro-1-(N-methyl-L-alanyl-3-methyl-L-valyl)cyclopenta[b]pyrrol-6-yl]-
1-Naphthalenecarboxamide, N-[(3aR,6S,6aS)-octahydro-1-(N-methyl-L-alanyl-3-methyl-L-valyl)cyclopenta[b]pyrrol-6-yl]-(866467-28-9)
- Name: 1-Naphthalenecarboxamide, N-[(3aR,6S,6aS)-octahydro-1-(N-methyl-L-alanyl-3-methyl-L-valyl)cyclopenta[b]pyrrol-6-yl]-
- Synonyms:1-NaphthalenecarboxaMide, N-[(3aR,6S,6aS)-octahydro-1-(N-Methyl-L-alanyl-3-Methyl-L-valyl)cyclopenta[b]pyrrol-6-yl]-;N-[(3aR,6S,6aS)-1-[(2S)-3,3-dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrol-6-yl]naphthalene-1-carboxamide
- Molecular Formula:C28H38N4O3
- Molecular Weight:478.635
- CAS Registry Number:866467-28-9
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 905311-24-2/PSB 601
- 46155-90-2/1H-Purine-2,6-dione, 3,4,5,9-tetrahydro-1,3-dimethyl-
- 1057677-92-5/2-(6-(4-(4-benzylphthalazin-1-yl)piperazin-1-yl)pyridin-3-yl)propan-2-ol
- 720690-73-3/GSK 189254A
- 1158838-43-7/Aurora A inhibitor II
- 861392-99-6/Benzeneacetamide, 4-chloro-N-[1-[[(cyanoamino)[(2-methyl-3-pyridinyl)imino]methyl]amino]-2,2-dimethylpropyl]-
- 1067647-43-1/1H-Indole-2,4-dione, 3-[2,5-dihydro-3-methyl-5-oxo-1-[4-(trifluoromethoxy)phenyl]-1H-pyrazol-4-yl]-3,5,6,7-tetrahydro-6,6-dimethyl-1-phenyl-3-(trifluoromethyl)-
- 145148-39-6/3-PiperidinaMine, N-[(2-Methoxyphenyl)Methyl]-2-phenyl-, (Hydrochloride) (1:2), (2S,3S)-
- 909106-60-1/A 876828
- 909106-97-4/A 924825
- 914088-64-5/Cazpaullone
- 700874-71-1/LY2109761
- 1025720-94-8/N-[4-[(2-Amino-3-chloropyridin-4-yl)oxy]-3-fluorophenyl]-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide
- 1003883-60-0/1,2-Pyrrolidinedicarboxamide, N1-(4-chlorophenyl)-N2-[(4-chlorophenyl)methyl]-N2-(2-hydroxyethyl)-, (2R)-
- 1003882-41-4/1,2-Pyrrolidinedicarboxamide, N2-[(4-chlorophenyl)methyl]-N2-methyl-N1-[4-(trifluoromethyl)phenyl]-, (2R)-
- 212790-31-3/CP 481715
- 864947-20-6/3-Azabicyclo[3.1.0]hexane-2-carboxamide, N-[1-(cyclopropylmethyl)-2,3-dioxo-3-(2-propen-1-ylamino)propyl]-3-[(2S)-2-[[[[(1S)-1-[(4,4-dimethyl-2,6-dioxo-1-piperidinyl)methyl]-2,2-dimethylpropyl]amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-
- 459133-38-1/Phenol, 5-[(7-chloro-4-quinolinyl)amino]-2-[[(1,1-dimethylethyl)amino]methyl]-
- 608141-41-9/ApreMilast
- 866467-28-9/1-Naphthalenecarboxamide, N-[(3aR,6S,6aS)-octahydro-1-(N-methyl-L-alanyl-3-methyl-L-valyl)cyclopenta[b]pyrrol-6-yl]-
- 957211-19-7/1(2H)-Quinolineethanol, 3,4-dihydro-2-[3-(1,1,2,2-tetrafluoroethoxy)phenyl]-5-[3-(trifluoromethoxy)phenyl]-a-(trifluoromethyl)-, (aS,2R)-
- 1044281-58-4/Imidazo[4,5,1-jk][1]benzazepin-2(1H)-one, 4,5,6,7-tetrahydro-7-hydroxy-6-[(1-methylethyl)amino]-, hydrochloride (1:1), (6R,7R)-
- 1117752-22-3/Imidazo[4,5,1-jk][1]benzazepin-2(1H)-one, 4,5,6,7-tetrahydro-7-hydroxy-6-[(1-methylethyl)amino]-, hydrochloride (1:1), (6S,7S)-
- 1025716-81-7/L-Valine, N-[[8-[(methoxycarbonyl)amino]-3-dibenzofuranyl]sulfonyl]-
- 260540-97-4/4-Quinolinamine, 7-chloro-N-[3-[[(1,1-dimethylethyl)amino]methyl]-4-fluorophenyl]-
- 1019839-52-1/Dibenzo[b,f][1,4]thiazepine-8-carboxamide, N-butyl-11-(3-chloro-4-fluorophenyl)-
- 872002-72-7/Quinoxaline, 6-[[4-[2-[4-(1,1-dimethylethyl)phenyl]-1H-benzimidazol-7-yl]-1-piperazinyl]methyl]-
- 884339-27-9/N-[4-[(2,3-dihydro-2-oxo-1H-imidazo[4,5-b]pyridin-7-yl)oxy]phenyl]-N'-[2-methoxy-5-(trifluoromethyl)phenyl]-
- 917369-31-4/N-(4-Methoxyphenyl)-N,2-dimethyl-4-quinazolinamine hydrochloride
- 1144161-05-6/Benzamide, N-[1,2-dihydro-2-(4-methoxyphenyl)-1-oxopyrido[2,3-e][1,2,4]triazolo[4,3-a]pyrazin-4-yl]-